| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |